RYAN ARTHUR F sold 0.6% of their position (100.00 shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $77.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−1.00
Price / share
$775.63
Trade value
$775.63
% of position
Common Stock
Shares
−10.00
Price / share
$776.59
Trade value
$7.77K
% of position
Common Stock
Shares
−57.00
Price / share
$777.56
Trade value
$44.32K
% of position
Common Stock
Shares
−12.00
Price / share
$778.53
Trade value
$9.34K
% of position
Common Stock
Shares
−5.00
Price / share
$779.41
Trade value
$3.90K
% of position
Common Stock
Shares
−1.00
Price / share
$780.09
Trade value
$780.09
% of position
Common Stock
Shares
−5.00
Price / share
$781.48
Trade value
$3.91K
% of position
Common Stock
Shares
−1.00
Price / share
$782.53
Trade value
$782.53
% of position
Common Stock
Shares
−3.00
Price / share
$783.34
Trade value
$2.35K
% of position
Common Stock
Shares
−1.00
Price / share
$784.59
Trade value
$784.59
% of position
Common Stock
Shares
−1.00
Price / share
$785.71
Trade value
$785.71
% of position
Common Stock
Shares
−2.00
Price / share
$786.29
Trade value
$1.57K
% of position
Common Stock
Shares
−1.00
Price / share
$787.82
Trade value
$787.82
% of position
Net shares
−100.00
Net value
-$77.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $775.63 | $775.63 | 0.0% | 17.90K | 17.90K |
| Common Stock Direct | 2/9/2026 | S · Sale | −10.00 | $776.59 | $7.77K | 0.1% | 17.90K | 17.89K |
| Common Stock Direct | 2/9/2026 | S · Sale | −57.00 | $777.56 | $44.32K | 0.3% | 17.89K | 17.84K |
| Common Stock Direct | 2/9/2026 | S · Sale | −12.00 | $778.53 | $9.34K | 0.1% | 17.84K | 17.82K |
| Common Stock Direct | 2/9/2026 | S · Sale | −5.00 | $779.41 | $3.90K | 0.0% | 17.82K | 17.82K |
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $780.09 | $780.09 | 0.0% | 17.82K | 17.82K |
| Common Stock Direct | 2/9/2026 | S · Sale | −5.00 | $781.48 | $3.91K | 0.0% | 17.82K | 17.81K |
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $782.53 | $782.53 | 0.0% | 17.81K | 17.81K |
| Common Stock Direct | 2/9/2026 | S · Sale | −3.00 | $783.34 | $2.35K | 0.0% | 17.81K | 17.81K |
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $784.59 | $784.59 | 0.0% | 17.81K | 17.81K |
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $785.71 | $785.71 | 0.0% | 17.81K | 17.81K |
| Common Stock Direct | 2/9/2026 | S · Sale | −2.00 | $786.29 | $1.57K | 0.0% | 17.81K | 17.80K |
| Common Stock Direct | 2/9/2026 | S · Sale | −1.00 | $787.82 | $787.82 | 0.0% | 17.80K | 17.80K |
| Total | −100.00 | -$77.85K | ||||||